The long-term survival outcome in older patients with different pathological types of chronic kidney disease

Kidney and Blood Pressure Research

Research Article

Open Access Gateway Yu F. · He G. · Hao W. · Hu W.
Abstract

Introduction: Chronic kidney diseases (CKD) are prevalent in older people and renal pathological manifestations are important for diagnosis, treatment and prognosis. However, the long-term survival outcome and risk factors for older CKD patients with different pathological types are not fully understood and need to be further investigated. Methods: Medical data were recorded and all-cause mortality were followed up in patients underwent renal biopsy diagnosed in Guangdong Provincial people hospital from 2005 to 2015. Kaplan-Meier analysis were used to identify the incidence of survival outcomes. Multivariate Cox regression models and Nomogram were applied to analyze pathological types and other factors for overall-survival outcomes. Results: 368 cases were included and the median of follow-up was 85 (46.5, 111) months. Overall mortality was 35.6%. The highest mortality was mesangioproliferative glomerulonephritis (MPGN) group (88.9%), followed by amyloidosis (AMY) group (84.6%), and the lowest mortality was minimal change disease (MCD) group (21.9%). Moreover, multivariate Cox regression model showed that survival times of MPGN (HR =8.215 [CI 95% 2.735, 24.674], p

The Author(s). Published by S. Karger AG, Basel

Article / Publication Details Open Access License / Drug Dosage / Disclaimer This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

留言 (0)

沒有登入
gif